SG Americas Securities
RDY icon

SG Americas Securities’s Dr. Reddy's Laboratories RDY Stock Holding History

SG Americas Securities’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367K Sell
25,316
-57,000
-69% -$769K ﹤0.01% 2479
2026
Q1 		$1.14M Buy
+82,316
New +$1.15M ﹤0.01% 1681
2025
Q1 		– Sell
-9,164
Closed -$145K – 3704
2024
Q4 		$145K Buy
+9,164
New +$138K ﹤0.01% 2440
2023
Q4 		– Sell
-48,375
Closed -$647K – 3385
2023
Q3 		$647K Buy
48,375
+8,290
+21% +$112K 0.01% 1572
2023
Q2 		$506K Sell
40,085
-345
-0.9% -$4.03K ﹤0.01% 1385
2023
Q1 		$460K Buy
40,430
+345
+0.9% +$3.72K 0.01% 1780
2022
Q4 		$415K Sell
40,085
-15,000
-27% -$162K 0.01% 1679
2022
Q3 		$577K Buy
55,085
+14,965
+37% +$159K 0.01% 1420
2022
Q2 		$444K Sell
40,120
-325,665
-89% -$3.54M ﹤0.01% 2055
2022
Q1 		$4.08M Buy
365,785
+210,740
+136% +$2.39M 0.03% 509
2021
Q4 		$2.03M Buy
+155,045
New +$1.95M 0.01% 1073
2021
Q2 		– Sell
-21,885
Closed -$269K – 3173
2021
Q1 		$269K Buy
21,885
+2,730
+14% +$35.1K ﹤0.01% 2470
2020
Q4 		$273K Buy
19,155
+11,515
+151% +$155K ﹤0.01% 2436
2020
Q3 		$106K Buy
+7,640
New +$91.1K ﹤0.01% 2443
2017
Q3 		– Sell
-17,085
Closed -$144K – 3695
2017
Q2 		$144K Buy
+17,085
New +$139K ﹤0.01% 2662
2017
Q1 		– Sell
-25,325
Closed -$229K – 3522
2016
Q4 		$229K Buy
+25,325
New +$236K ﹤0.01% 2255

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

SG Americas Securities's RDY Position: Q2 2026 in Review

SG Americas Securities reduced its Dr. Reddy's Laboratories (RDY) stake by 69% in Q2 2026, selling an estimated $769K and leaving 25,316 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #2479.

SG Americas Securities first reported a position in RDY in Q4 2016 and has held it in 16 quarters since. The position peaked at $4.08M in Q1 2022. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • SG Americas Securities held 25,316 shares of Dr. Reddy's Laboratories worth $367K as of Q2 2026.
  • SG Americas Securities sold 57,000 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $769K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2479 holding.
  • SG Americas Securities first reported a position in Dr. Reddy's Laboratories in Q4 2016 and has held it in 16 quarters since.
  • SG Americas Securities's Dr. Reddy's Laboratories position peaked at $4.08M in Q1 2022.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.